{
    "clinical_study": {
        "@rank": "112684", 
        "arm_group": {
            "arm_group_label": "GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, multicenter, single arm feasibility study of the safety and\n      performance of the GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122  in patients who require\n      cartilage replacement."
        }, 
        "brief_title": "A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122 in the Treatment of Degenerative Joint Disease of the Hip", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Degenerative Joint Disease of the Hip", 
        "condition_browse": {
            "mesh_term": [
                "Joint Diseases", 
                "Osteoarthritis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Primary hip surgery for Noninflammatory Degenerative Joint Disease (NIDJD) such as\n             osteo/degenerative arthritis, and is indicated for cartilage replacement\n\n          -  Skeletally mature or at least 18 years of age and has normal anatomy\n\n          -  Patient signs the Informed Consent form\n\n          -  Failed medical management\n\n          -  There will be size limitations on patients also - available size range is 46mm-54mm.\n\n        Exclusion Criteria:\n\n          -  Allergic to polyether urethane, sodium polyacrylate, bone cement or any of its\n             components\n\n          -  Previous fusion, acute femoral neck fracture and/or above knee amputation\n\n          -  Revision of any previous hip procedure\n\n          -  Slipped capital femoral epiphysis (SCFE)\n\n          -  Rheumatoid arthritis\n\n          -  AVN"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01982266", 
            "org_study_id": "EP052"
        }, 
        "intervention": {
            "arm_group_label": "GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122", 
            "intervention_name": "GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 6, 2013", 
        "location": {
            "contact": {
                "last_name": "JLC van Susante, Dr.", 
                "phone": "088-0058888"
            }, 
            "facility": {
                "address": {
                    "city": "Arnhem", 
                    "country": "Netherlands", 
                    "zip": "6815"
                }, 
                "name": "Rijnstate Arnhem"
            }, 
            "investigator": {
                "last_name": "JLC van Susante, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION\u2122 Hip Total Cartilage Replacement (TCR)\u2122 in the Treatment of Degenerative Joint Disease of the Hip", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: Dutch Health Care Inspectorate", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01982266"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Biomimedica, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biomimedica, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}